I agree. It will be an event that should spark interest from investors. The $25K per valve has been suggested with confidence so I do not think that is an unknown. 400 participants is better than the earlier number of 1000 being postulated (not with any evidence). now it is just how long people are willing to hang on. If there is a price drift past trial completion awaiting FDA approval, it might be an opportunity to top up,,,(barring a catastrophic failure) in anticipation of impending activity.
New 6-month low, or 24-month low?, page-11
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |